To investigate the clinical effect of KTP/532 laser for concurrent hemorrhage of late stage prostate cancer. Methods From March 2005 to March 2010, 36 cases of late stage prostate cancer with concurrent hemorrhage received transiiretkral KTP/532 laser vaporization of prostate, the clinical characteristics of cases, diagnosis and treatment were reviewed and analysed. Results The procedure was performed without complication and hemostasis was achieved successfully in all cases. The operation time was 25～45 minutes( average 38 minutes). All patients had got normal voiding after removal of catheter 3～4d postoperatively with clear urine. All cases were followed up, the follow-up duration ranged from 4～23 months ( average 11 months). 8 patients developed recurrence of prostate hemorrhage during the long term follow up(3 cases recurred at 3 ～6 months postoperatively, 5 cases recurred at 7～18 months postoperatively ). All recurrent patients received the same operations and hemostasis was achieved successfully again. Conclusion As an easy procedure, transurethral KTP/532 User vaporization of prostate for late stage prostate cancer with concurrent hemorrhage is safe and effective, and the postoperative recovery is quickly.%目的 探讨KTP/532激光治疗晚期前列腺癌并发出血的临床效果.方法 2005年3月～2010年3月,采用经尿道KTP/532激光汽化前列腺癌组织治疗晚期前列腺癌并发出血患者36例,回顾分析相关临床诊治资料.结果 36例均止血成功.手术时间25 ～ 45 min,平均38min；术后3～4d拔除导尿管,尿液清亮,排尿均通畅.所有患者获得随访(4～23个月,平均11个月),其中8例出血复发(3例术后3～6个月复发,5例术后7～18个月复发).对复发患者,再次采用本方法治疗,均能有效止血.结论 KTP/532激光治疗晚期前列腺癌并发出血效果良好、手术操作简单、术后恢复快,重复应用有效.
展开▼
